# Phase 2 Trial of LACTIN-V in Women at High Risk of HIV Acquisition

> **NCT05022212** · PHASE2 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 45 (actual)

## Conditions studied

- Bacterial Vaginosis
- HIV Infections

## Interventions

- **DRUG:** LACTIN-V
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05022212
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-10
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-03-31
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2024-08-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05022212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05022212, "Phase 2 Trial of LACTIN-V in Women at High Risk of HIV Acquisition". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05022212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*